Published :
Tables : 58
Figures : 43
Category : Healthcare
No. of Pages : 221
Report Code : HC-U3077
Circulating Tumor Cells Market is forecasted to value over USD 13.78 billion by 2027 end and register a CAGR of 16% from the forecast period 2020-2027. FutureWise Market Research has instantiated a report that provides an intricate analysis of Circulating Tumor Cells Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Circulating Tumor Cells Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Circulating Tumor Cells Market are : • JANSSEN • QIAGEN(ADNAGEN) • Acousys Biodevices, Inc • ApoCell • Advanced Cell Diagnostics • Fluxion Biosciences • Biocept • Fluidigm • Epic Sciences • Clearbridge Biomedics (Note: The list of the major players will be updated with the latest market scenario and trends) Circulating Tumor Cells Market Segmentation: By Technology CTC Detection & Enrichment Methods Immunocapture (Label-based) Positive Selection Negative Selection Size-based Separation (Label-free) Membrane-based Microfluidic-based Density-based Separation (Label-free) Combined Methods CTC Direct Detection Methods SERS Microscopy Others CTC Analysis By Application Clinical/ Liquid Biopsy Risk Assessment Screening and Monitoring Research Cancer Stem Cell & Tumorigenesis Research Drug/Therapy Development By Product Kits & Reagents Blood Collection Tubes Devices or Systems By Specimen Blood Bone Marrow By Region • North America • Europe • Asia-Pacific • Rest of the world Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Circulating Tumor Cells Market by technology, by application, by product, by specimen and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Circulating Tumor Cells Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Circulating Tumor Cells Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Circulating Tumor Cells Market are : • JANSSEN • QIAGEN(ADNAGEN) • Acousys Biodevices, Inc • ApoCell • Advanced Cell Diagnostics • Fluxion Biosciences • Biocept • Fluidigm • Epic Sciences • Clearbridge Biomedics (Note: The list of the major players will be updated with the latest market scenario and trends) Circulating Tumor Cells Market Segmentation:
By Technology
By Application
By Product
By Specimen
By Region • North America • Europe • Asia-Pacific • Rest of the world Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Circulating Tumor Cells Market by technology, by application, by product, by specimen and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Circulating Tumor Cells Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Circulating Tumor Cells Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Circulating Tumor Cells Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Circulating Tumor Cells Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Circulating Tumor Cells Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million) 7.1 CTC Detection & Enrichment Methods 7.1.1. Immunocapture (Label-based) 7.1.1.1. Positive Selection 7.1.1.2. Negative Selection 7.1.2. Size-based Separation (Label-free) 7.1.2.1. Membrane-based 7.1.2.2. Microfluidic-based 7.1.3. Density-based Separation (Label-free) 7.1.4. Combined Methods 7.2 CTC Direct Detection Methods 7.2.1. SERS 7.2.2. Microscopy 7.2.3. Others 7.3 CTC Analysis 8. Global Circulating Tumor Cells Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Clinical/ Liquid Biopsy 8.1.1. Risk Assessment 8.1.2. Screening and Monitoring 8.2.Research 8.2.1. Cancer Stem Cell & Tumorigenesis Research 8.2.2. Drug/Therapy Development 9. Global Circulating Tumor Cells Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Kits & Reagents 9.2. Blood Collection Tubes 9.2. Devices or Systems 10. Global Circulating Tumor Cells Market, By Specimen Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Blood 10.2. Bone Marrow 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 16.1 JANSSEN 16.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2 QIAGEN(ADNAGEN) 16.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3 Acousys Biodevices, Inc 16.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4 ApoCell 16.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Advanced Cell Diagnostics 16.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Fluxion Biosciences 16.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7 Biocept 16.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8 Fluidigm 16.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9 Epic Sciences 16.9.1. Company Overview (HQ, Business Segments, Employee Strength) 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10 Clearbridge Biomedics 16.10.1. Company Overview (HQ, Business Segments, Employee Strength) 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 17. FutureWise SME Key Takeaway Points for Client
1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Scope
1.3.1. Years Considered for the Study
1.3.2. Market Covered
1.4. Currency
1.5. Limitations
1.6. Stakeholders
2. Research Methodology
2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data
2.1.2.1. Key Data from Primary Sources
2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation
2.4. Assumptions for the Study
3. Executive Summary
3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Circulating Tumor Cells Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Global Circulating Tumor Cells Market Overview
5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Circulating Tumor Cells Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Circulating Tumor Cells Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Circulating Tumor Cells Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)
7.1 CTC Detection & Enrichment Methods
7.1.1. Immunocapture (Label-based)
7.1.1.1. Positive Selection
7.1.1.2. Negative Selection
7.1.2. Size-based Separation (Label-free)
7.1.2.1. Membrane-based
7.1.2.2. Microfluidic-based
7.1.3. Density-based Separation (Label-free)
7.1.4. Combined Methods
7.2 CTC Direct Detection Methods
7.2.1. SERS
7.2.2. Microscopy
7.2.3. Others
7.3 CTC Analysis
8. Global Circulating Tumor Cells Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Clinical/ Liquid Biopsy
8.1.1. Risk Assessment
8.1.2. Screening and Monitoring
8.2.Research
8.2.1. Cancer Stem Cell & Tumorigenesis Research
8.2.2. Drug/Therapy Development
9. Global Circulating Tumor Cells Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. Kits & Reagents
9.2. Blood Collection Tubes
9.2. Devices or Systems
10. Global Circulating Tumor Cells Market, By Specimen Historical Analysis and Forecast 2020-2027 (USD Million)
10.1. Blood 10.2. Bone Marrow
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.2.1. U.S.A
11.2.2. Canada
11.2.3. Mexico
11.3. Market Size (USD Million) Forecast for North America 2020-2027
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.2.1. Brazil
12.2.2. Venezuela
12.2.3. Argentina
12.2.4. Rest of Latin America
12.3. Market Size (USD Million) Forecast for Latin America 2020-2027
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Germany
13.2.2. U.K
13.2.3. France
13.2.4. Italy
13.2.5. Spain
13.2.6. Russia
13.2.7. Poland
13.2.8. Rest of Europe
13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
14.2.1. Japan
14.2.2. China
14.2.3. India
14.2.4. Australia and New Zealand
14.2.5. ASEAN
14.2.6. Rest of Asia Pacific
14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
15.1. Introduction
15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
15.2.1. Saudi Arabia
15.2.2. UAE
15.2.3. South Africa
15.2.4. Egypt
15.3. Market Size (USD Million) Forecast for MEA 2020-2027
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
16.1 JANSSEN
16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.1.2. Product Portfolio
16.1.3. SWOT Analysis
16.1.4. Financial Overview
16.1.5. Strategic Overview
16.2 QIAGEN(ADNAGEN)
16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2. Product Portfolio
16.2.3. SWOT Analysis
16.2.4. Financial Overview
16.2.5. Strategic Overview
16.3 Acousys Biodevices, Inc
16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2. Product Portfolio
16.3.3. SWOT Analysis
16.3.4. Financial Overview
16.3.5. Strategic Overview
16.4 ApoCell
16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.2. Product Portfolio
16.4.3. SWOT Analysis
16.4.4. Financial Overview
16.4.5. Strategic Overview
16.5 Advanced Cell Diagnostics
16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.2. Product Portfolio
16.5.3. SWOT Analysis
16.5.4. Financial Overview
16.5.5. Strategic Overview
16.6 Fluxion Biosciences
16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.6.2. Product Portfolio
16.6.3. SWOT Analysis
16.6.4. Financial Overview
16.6.5. Strategic Overview
16.7 Biocept
16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.7.2. Product Portfolio
16.7.3. SWOT Analysis
16.7.4. Financial Overview
16.7.5. Strategic Overview 16.8 Fluidigm
16.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.8.2. Product Portfolio
16.8.3. SWOT Analysis
16.8.4. Financial Overview
16.8.5. Strategic Overview
16.9 Epic Sciences
16.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.9.2. Product Portfolio
16.9.3. SWOT Analysis
16.9.4. Financial Overview
16.9.5. Strategic Overview
16.10 Clearbridge Biomedics
16.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.10.2. Product Portfolio
16.10.3. SWOT Analysis
16.10.4. Financial Overview
16.10.5. Strategic Overview
17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics